HRT Financial’s Astera Labs ALAB Stock Holding History

HRT Financial’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-23,600	Closed	-$3.93M	–	4911
2025 Q4	$3.93M	Buy	23,600 +1,300	+6%	+$217K	0.01%	896
2025 Q3	$4.37M	Buy	+22,300	New	+$3.67M	0.02%	733

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

HRT Financial's ALAB Position: Q2 2025 in Review

HRT Financial sold out of Astera Labs (ALAB) in Q2 2025, closing a stake of 31,536 shares — an estimated $1.88M sold.

HRT Financial first reported a position in ALAB in Q3 2024 and held it in 2 quarters. The position peaked at $23.8M in Q3 2024. 513 funds tracked by Wall St. Rank hold ALAB as of Q2 2025.

HRT Financial reported no remaining Astera Labs position as of Q2 2025 after selling out during the quarter.
HRT Financial sold 31,536 Astera Labs shares in Q2 2025, an estimated $1.88M.
HRT Financial first reported a position in Astera Labs in Q3 2024 and held it in 2 quarters.
HRT Financial's Astera Labs position peaked at $23.8M in Q3 2024.
513 funds tracked by Wall St. Rank held Astera Labs as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.